Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”

by Romain Eychenne, Michel Chérel, Férid Haddad, François Guérard, Jean-François Gestin
Published 2021-06-01

Immuno-PET: Design options and clinical proof-of-concept

by Alexandre Lugat, Clément Bailly, Clément Bailly, Michel Chérel, Michel Chérel, Caroline Rousseau, Caroline Rousseau, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2022-10-01

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives

by Nicolas Lepareur, Nicolas Lepareur, Franck Lacœuille, Franck Lacœuille, Christelle Bouvry, Christelle Bouvry, François Hindré, François Hindré, Emmanuel Garcion, Emmanuel Garcion, Michel Chérel, Michel Chérel, Nicolas Noiret, Nicolas Noiret, Etienne Garin, Etienne Garin, F. F. Russ Knapp
Published 2019-06-01

Cell Tracking in Cancer Immunotherapy

by Justine Perrin, Marisa Capitao, Marie Mougin-Degraef, Marie Mougin-Degraef, François Guérard, Alain Faivre-Chauvet, Alain Faivre-Chauvet, Latifa Rbah-Vidal, Joëlle Gaschet, Yannick Guilloux, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Jacques Barbet
Published 2020-02-01

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells

by Delphine Séhédic, Loris Roncali, Amel Djoudi, Nela Buchtova, Sylvie Avril, Michel Chérel, Frank Boury, Franck Lacoeuille, François Hindré, Emmanuel Garcion
Published 2021-02-01

From bench to bedside: 64Cu/177Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications

by Silvano Gnesin, Nicolas Chouin, Michel Cherel, Steven Mark Dunn, Niklaus Schaefer, Alain Faivre-Chauvet, John O. Prior, Judith Anna Delage
Published 2023-06-01

Long-Term Toxicity of 213Bi-Labelled BSA in Mice.

by Laëtitia Dorso, Edith Bigot-Corbel, Jérôme Abadie, Maya Diab, Sébastien Gouard, Frank Bruchertseifer, Alfred Morgenstern, Catherine Maurel, Michel Chérel, François Davodeau
Published 2016-01-01

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

by Clément Bailly, Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Françoise Kraeber-Bodéré, Michel Chérel, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Caroline Bodet-Milin, Mickaël Bourgeois, Mickaël Bourgeois, Mickaël Bourgeois
Published 2019-07-01

Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies

by Caroline Dagallier, Caroline Dagallier, François Avry, Yann Touchefeu, Yann Touchefeu, Frédéric Buron, Sylvain Routier, Michel Chérel, Nicolas Arlicot, Nicolas Arlicot, Nicolas Arlicot
Published 2021-06-01

Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture

by Clément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, Sébastien Gouard, Catherine Ansquer, Matthieu Barbaud, Jean-Charles Sébille, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier
Published 2019-08-01

A role for ceruloplasmin in the control of human glioblastoma cell responses to radiation

by Charlotte Roy, Sylvie Avril, Claire Legendre, Bénédicte Lelièvre, Honorine Vellenriter, Sébastien Boni, Jérôme Cayon, Catherine Guillet, Yannick Guilloux, Michel Chérel, François Hindré, Emmanuel Garcion
Published 2022-08-01

Antitumor Immunity Induced after α Irradiation

by Jean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, Catherine Maurel, Yannick Guilloux, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, François Davodeau, Joëlle Gaschet
Published 2014-04-01

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

by Clément Bailly, Rodolphe Leforestier, Bastien Jamet, Thomas Carlier, Mickael Bourgeois, François Guérard, Cyrille Touzeau, Philippe Moreau, Michel Chérel, Françoise Kraeber-Bodéré, Caroline Bodet-Milin
Published 2017-02-01

64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study

by Elodie A. Pérès, Jérôme Toutain, Louis-Paul Paty, Didier Divoux, Méziane Ibazizène, Stéphane Guillouet, Louisa Barré, Aurélien Vidal, Michel Cherel, Mickaël Bourgeois, Myriam Bernaudin, Samuel Valable
Published 2019-12-01

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

by Hélène Grégoire, Loris Roncali, Audrey Rousseau, Audrey Rousseau, Michel Chérel, Yves Delneste, Yves Delneste, Pascale Jeannin, Pascale Jeannin, François Hindré, François Hindré, Emmanuel Garcion, Emmanuel Garcion
Published 2020-04-01

Immuno-PET for Clinical Theranostic Approaches

by Clément Bailly, Pierre-François Cléry, Alain Faivre-Chauvet, Mickael Bourgeois, François Guérard, Ferid Haddad, Jacques Barbet, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier, Caroline Bodet-Milin
Published 2016-12-01

Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model

by Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, Frank Bruchertseifer, Alfred Morgenstern, Latifa Rbah-Vidal, Michel Chérel, Emmanuel Scotet, Nathalie Labarrière, Yannick Guilloux, Joëlle Gaschet
Published 2021-03-01

ImmunoPET in Multiple Myeloma—What? So What? Now What?

by Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin, Michel Chérel
Published 2020-06-01

Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease

by Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clément Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Chérel
Published 2020-09-01

Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.

by Jérémie Ménager, Jean-Baptiste Gorin, Catherine Maurel, Lucile Drujont, Sébastien Gouard, Cédric Louvet, Michel Chérel, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, François Davodeau, Joëlle Gaschet, Yannick Guilloux
Published 2015-01-01